Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | LOX | P28300 | 1/20 | 0.30 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.30 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16672479 | 1.00 | TSHR (0.40) | TSHRALDH1A1TDP1MAPTLOX | |
| SCHEMBL23700068 | 1.00 | TSHR (0.40) | TSHRALDH1A1TDP1MAPTLOX | |
| SCHEMBL23700089 | 1.00 | TSHR (0.40) | TSHRALDH1A1TDP1MAPTLOX | |
| SCHEMBL23700073 | 1.00 | TSHR (0.40) | TSHRALDH1A1TDP1MAPTLOX | |
| SCHEMBL819884 | 0.97 | TSHR (0.42) | TSHRALDH1A1TDP1MAPTLOX | |
| SCHEMBL819764 | 0.88 | TSHR (0.43) | TSHRALDH1A1TDP1MAPTLOX | |
| SCHEMBL22996729 | 0.88 | — | — | |
| SCHEMBL819370 | 0.85 | TSHR (0.30) | TSHR | |
| SCHEMBL17935752 | 0.80 | TSHR (0.42) | TSHRALDH1A1TDP1MAPTLOX | |
| SCHEMBL17935685 | 0.80 | TSHR (0.42) | TSHRALDH1A1TDP1MAPTLOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 789 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122091751-A | Composite electrolyte additive composition, electrolyte, preparation and application | — | 2026-05-26 | — | — | CN | claimed |
| EP-4736245-A1 | ELECTROCHEMICAL ELEMENT WITH ADDITIVES IN THE ELECTROLYTE AND LITHIUM PHOSPHATE-BASED ELECTRODE | SAFT (FR) | 2026-05-06 | — | — | EP | claimed |
| US-20260081220-A1 | LITHIUM-ION BATTERY | SHENZHEN CAPCHEM TECHNOLOGY CO LTD (CN) | 2026-03-19 | — | — | US | claimed |
| US-20260074283-A1 | LITHIUM-ION BATTERY | SHENZHEN CAPCHEM TECHNOLOGY CO LTD (CN) | 2026-03-12 | — | — | US | claimed |
| US-20260062817-A1 | METHOD FOR ELECTROLYTIC REDUCTION OF ACRYLONITRILE TO PRODUCE ADIPONITRILE AND HEXANETRICARBONITRILE | UNIV EAST CHINA SCIENCE & TECH (CN) | 2026-03-05 | — | — | US | claimed |
| EP-4123759-B1 | NEGATIVE ELECTRODE PLATE AND LITHIUM-ION SECONDARY BATTERY | CONTEMPORARY AMPEREX TECHNOLOGY HONG KONG LTD (HK) | 2026-01-21 | — | — | EP | claimed |
| EP-3251133-B1 | WIDE OPERATING TEMPERATURE RANGE (0° TO 275°C) ULTRACAPACITOR | FASTCAP ULTRACAPACITORS LLC (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4668402-A1 | ELECTROLYTE AND BATTERY | Zhuhai CosMX Battery Co., Ltd. (CN) | 2025-12-24 | — | — | EP | claimed |
| US-20250385307-A1 | LITHIUM-ION BATTERY | SHENZHEN CAPCHEM TECHNOLOGY CO LTD (CN) | 2025-12-18 | — | — | US | claimed |
| US-20250372715-A1 | ELECTROLYTE AND BATTERY | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2025-12-04 | — | — | US | claimed |
| US-20120154979-A1 | Electrochemical double-layer capacitor for high temperature applications | WINDSAIL CAPITAL FUND, L.P. | 2012-06-21 | — | — | US | claimed |
| US-20120156528-A1 | Battery-capacitor hybrid energy storage system for high temperature applications | WINDSAIL CAPITAL FUND, L.P. | 2012-06-21 | — | — | US | claimed |
| US-20100112455-A1 | SOLVENTS AND NOVEL ELECTROLYTIC COMPOSITIONS HAVING A LARGE RANGE OF STABILITY AND HIGH CONDUCTIVITY | ACEP INC. (CA) | 2010-05-06 | — | — | US | claimed |
| US-20090206299-A1 | SOLVENTS AND NOVEL ELECTROLYTIC COMPOSITIONS HAVING A LARGE RANGE OF STABILITY AND HIGH CONDUCTIVITY | ACEP INC. (CA) | 2009-08-20 | — | — | US | claimed |
| CN-100439312-C | Polycarboxylic acid mixture | ASAHI CHEMICAL IND (JP) | 2008-12-03 | — | — | CN | claimed |
| US-20060188788-A1 | Solvents and novel electrolytic compositions having a large range of stability and high conductivity | ACEP INC. (CA) | 2006-08-24 | — | — | US | claimed |
| CN-1610656-A | Polycarboxylic acid mixture | ASAHI CHEMICAL IND (JP) | 2005-04-27 | — | — | CN | claimed |
| US-20030162096-A1 | Solvents and novel electrolytic compositions having a large range of stability and high conductivity | ACEP INC. (CA) | 2003-08-28 | — | — | US | claimed |
| US-6296973-B1 | APROTIC POLAR COMPOUNDS AND SOLVENTS | HYDRO - QUEBEC (CA) | 2001-10-02 | — | — | US | claimed |
| US-20010012591-A1 | Solvents and novel electrolytic compositions having a large range of stability and high conductivity | ACEP INC. (CA) | 2001-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260074283-A1 | LITHIUM-ION BATTERY | SCN10A, CACNA1F, SCN2B | TSHR 3521/4885ALDH1A1 1620/4885TDP1 3557/4885 |
| US-20260081220-A1 | LITHIUM-ION BATTERY | CACNA1F, CACNA2D1, LEF1 | TSHR 2381/4885ALDH1A1 3759/4885TDP1 3525/4885 |
| US-20060188788-A1 | Solvents and novel electrolytic compositions having a large range of stability and high conductivity | AQP1, HCN2, HCN1 | TSHR 4430/4885ALDH1A1 2775/4885TDP1 3288/4885 |
| US-20090206299-A1 | SOLVENTS AND NOVEL ELECTROLYTIC COMPOSITIONS HAVING A LARGE RANGE OF STABILITY AND HIGH CONDUCTIVITY | AQP1, HCN2, HCN1 | TSHR 4430/4885ALDH1A1 2775/4885TDP1 3288/4885 |
| US-20260062817-A1 | METHOD FOR ELECTROLYTIC REDUCTION OF ACRYLONITRILE TO PRODUCE ADIPONITRILE AND HEXANETRICARBONITRILE | HCN4, IDH1, IDH3A | TSHR 2484/4885ALDH1A1 153/4885TDP1 1784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.